SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2023 SESSION
Unfinished Business - Senate
prev | next | current | calendar
S.B. 1337.
A BILL to amend and reenact §§ 54.1-3408.3, 54.1-3442.5,
54.1-3442.6, and 54.1-3442.7 of the Code of Virginia and to amend the Code of
Virginia by adding sections numbered 54.1-3442.7:1,
54.1-3442.7:2, and 54.1-3442.7:3, relating to medical marijuana program;
product, registration, dispensing, and recordkeeping requirements; advertising. 23106171D
- 02/02/23 Senate: Committee substitute printed 23106171D-S1
- 01/11/23 Senate: Prefiled and ordered printed; offered 01/11/23 23104097D
Patron--Dunnavant
Referred to Committee on Rehabilitation and Social Services January 11, 2023
Passed Senate February 7, 2023 (30-Y 10-N)
Passed House with amendments
February 21, 2023
(70-Y 27-N)
AMENDMENT(S) PROPOSED BY THE HOUSE OF DELEGATES HEALTH, WELFARE AND INSTITUTIONS
HEALTH, WELFARE AND INSTITUTIONS
1. Line 60, engrossed, after certification.
insert
A pharmaceutical processor shall not (i) endorse or promote any
practitioner who issues certifications to patients or (ii) advertise that it
facilitates the issuance of written certifications.
2. Line 63, engrossed, after dispensing.
insert
A practitioner who issues written certifications shall not
directly or indirectly accept, solicit, or receive anything of value from a
pharmaceutical processor, cannabis dispensing facility, or any person
associated with a pharmaceutical processor, cannabis dispensing facility, or
provider of paraphernalia, excluding information on products or educational
materials on the benefits and risks of cannabis products.